Joined Today: 14

BIOD Biodel, Stock Message Board

All Messages

#4: Biodel Announces Preliminary Results of Pivotal Phase III Clinical Trials for VIAject(TM)
TheMachine	September 20, 2008 01:09:05 AM
Clinical Trials Meet Primary Endpoint of Non-Inferiority and Demonstrate Statistically Significant Reductions in Hypoglycemic Events and Weight Gain Results... view message ignore post recommend post

#3: BIOD Stock: Biodel Inc. Reports Third Quarter Fiscal Year 2008 Financial Results
NewsBot	August 14, 2008 10:22:06 AM
Biodel Inc. (Nasdaq: BIOD stock) today reported financial results for its third quarter ended June 30, 2008. The net loss for the quarter was $10.1 million or $0.43 per share. ... view message ignore post recommend post

#2: Biodel Inc. Completes Enrollment of Two Pivotal Phase III Clinical Trials of VIAject(TM) and Plans Manufacturing Facility for VIAject(TM)
NewsBot	January 4, 2008 08:21:37 AM
DANBURY, Conn., Jan. 3 /PRNewswire-FirstCall/ -- Biodel Inc. (Nasdaq: BIOD) today announced that the Company has completed enrollment of its two pivotal Phase III clinical trials of VIAject(TM),... view message ignore post recommend post

#1: BIOD, Biodel Inc. Announces Completion of Public Offering
Jason	May 29, 2007 08:18:55 AM
Biodel Inc. (Nasdaq: BIOD Nasdaq Drug Stocks) today announced it has completed its initial public offering. Biodel sold a total of 5,750,000 shares of its common stock, which included 750,000... view message ignore post recommend post

Group Home | Login if you want to post a message